AXA Framlington Biotech Fund - R Income
Category Sector Equity Biotechnology
Last buy/sell price
284.60p
-2.50p (-0.87%)
Fund Code
3100725
GB0031007254
Prices updated as at 18 Oct 2024
Prices in GBX
Investment objective
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed companies, principally in the biotechnology, genomic and medical research industry, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world, albeit the Fund tends to be biased towards the US as this is where the majority of biotechnology companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
Growth of 1,000 as of 19 Oct 2024, 15:10
Trailing returns (%) as of 19 Oct 2024, 15:10
Annual performance (%)
| Year | This fund | Sector Equity Biotechnology |
|---|---|---|
| 30 Sep 13 - 30 Sep 14 | 30.89 | 24.65 |
| 30 Sep 14 - 30 Sep 15 | 13.31 | 12.71 |
| 30 Sep 15 - 30 Sep 16 | 10.01 | 12.30 |
| 30 Sep 16 - 30 Sep 17 | 11.31 | 13.25 |
| 30 Sep 17 - 30 Sep 18 | 13.45 | 8.79 |
| 30 Sep 18 - 30 Sep 19 | -17.91 | -13.83 |
| 30 Sep 19 - 30 Sep 20 | 41.74 | 31.81 |
| 30 Sep 20 - 30 Sep 21 | 10.66 | 5.67 |
| 30 Sep 21 - 30 Sep 22 | 1.59 | -16.37 |
| 30 Sep 22 - 30 Sep 23 | -7.27 | -9.58 |
| 30 Sep 23 - 30 Sep 24 | 10.89 | 5.94 |
Trailing returns (%)
| Year | This fund | Sector Equity Biotechnology |
|---|---|---|
| 1 Day | -0.87 | -0.07 |
| 1 Month | 0.81 | 2.75 |
| 3 Months | - | 1.45 |
| 6 Months | 12.76 | 9.19 |
| 1 Year | 17.41 | 20.41 |
| 3 Years annualised | 4.51 | -2.18 |
| 5 Years annualised | 11.98 | 9.57 |
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
